Wells Fargo’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Sell |
22,749
-5,490
| -19% | -$34.4K | ﹤0.01% | 4578 |
|
|
2025
Q1 | $165K | Buy |
28,239
+616
| +2% | +$3.61K | ﹤0.01% | 4384 |
|
|
2024
Q4 | $227K | Buy |
27,623
+5,930
| +27% | +$48.7K | ﹤0.01% | 4241 |
|
|
2024
Q3 | $193K | Buy |
21,693
+914
| +4% | +$8.14K | ﹤0.01% | 4217 |
|
|
2024
Q2 | $157K | Buy |
20,779
+7,764
| +60% | +$58.7K | ﹤0.01% | 4310 |
|
|
2024
Q1 | $102K | Buy |
13,015
+4,399
| +51% | +$34.5K | ﹤0.01% | 4517 |
|
|
2023
Q4 | $76.3K | Buy |
8,616
+1,841
| +27% | +$16.3K | ﹤0.01% | 4662 |
|
|
2023
Q3 | $60.8K | Sell |
6,775
-3,655
| -35% | -$32.8K | ﹤0.01% | 4735 |
|
|
2023
Q2 | $129K | Buy |
10,430
+5,869
| +129% | +$72.5K | ﹤0.01% | 4612 |
|
|
2023
Q1 | $42.3K | Buy |
+4,561
| New | +$42.3K | ﹤0.01% | 4959 |
|
|
2022
Q4 | – | Sell |
-310
| Closed | -$6K | – | 7122 |
|
|
2022
Q3 | $6K | Sell |
310
-120
| -28% | -$2.32K | ﹤0.01% | 5510 |
|
|
2022
Q2 | $6K | Sell |
430
-791
| -65% | -$11K | ﹤0.01% | 5632 |
|
|
2022
Q1 | $27K | Sell |
1,221
-2,047
| -63% | -$45.3K | ﹤0.01% | 5560 |
|
|
2021
Q4 | $55K | Buy |
+3,268
| New | +$55K | ﹤0.01% | 5480 |
|